These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 10330194)
1. Prediction of Biologic Aggressiveness in Colorectal Cancer by p53/K-ras-2 Topographic Genotyping. Finkelstein SD; Przygodzki R; Pricolo VE; Sakallah SA; Swalsky PA; Bakker A; Lanning R; Bland KI; Cooper DL Mol Diagn; 1996 Jun; 1(1):5-28. PubMed ID: 10330194 [TBL] [Abstract][Full Text] [Related]
2. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers. Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283 [TBL] [Abstract][Full Text] [Related]
6. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618 [TBL] [Abstract][Full Text] [Related]
7. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas. Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933 [TBL] [Abstract][Full Text] [Related]
8. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Slebos RJ; Hoppin JA; Tolbert PE; Holly EA; Brock JW; Zhang RH; Bracci PM; Foley J; Stockton P; McGregor LM; Flake GP; Taylor JA Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1223-32. PubMed ID: 11097231 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection. Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632 [TBL] [Abstract][Full Text] [Related]
10. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection. Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622 [TBL] [Abstract][Full Text] [Related]
12. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
13. GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysis. Curigliano G; Ferretti G; Mandalà M; De Pas T; Calabrò MG; Solli P; Noberasc C; de Braud F Anticancer Res; 2001; 21(5):3461-9. PubMed ID: 11848510 [TBL] [Abstract][Full Text] [Related]
14. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection. Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240 [TBL] [Abstract][Full Text] [Related]
15. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer. Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767 [TBL] [Abstract][Full Text] [Related]
16. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances]. Fu XY; Bin XN; Tan M Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539 [TBL] [Abstract][Full Text] [Related]
17. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy. Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755 [TBL] [Abstract][Full Text] [Related]